Travere Therapeutics (TVTX)

Travere Therapeutics (TVTX) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.

• TVTX last traded at $48.70, -3.35% on the day.
• Travere Therapeutics: P/E -108.4, revenue $591.33M over the last four quarters.
• Over the past year TVTX returned 64.25%; year to date 27.45%.

Updated 2026-11-02 19:09 UTC